United Therapeutics Corp (UTHR) Easily Beats Q3 Views; Revs Top $200M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $587.47 -0.91%
EPS Growth %: -13.3%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
OMID, SICP, SCKT, More
EPS Growth %: -13.3%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
United Therapeutics Corp (NASDAQ: UTHR) reported Q3 EPS of $1.65, $0.92 better than the analyst estimate of $0.73. Revenue for the quarter came in at $201.7 million versus the consensus estimate of $194.77 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Therapeutics Corp. (UTHR) PT Raised to $850 at Cantor Fitzgerald
- CenterPoint Energy (CNP) Tops Q3 EPS by 4c; offers guidance
- Johnson Controls (JCI) Tops Q4 EPS by 1c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
